Role of BMSCs in liver regeneration and metastasis after hepatectomy

World Journal of Gastroenterology

Volumn 20, Issue 1, 2014, Pages 126-132

  Hang, Hua Lian ^a   Xia, Qiang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Bone marrow stromal cells; Liver cancer; Liver metastasis; Liver regeneration

Indexed keywords

FIBROBLAST GROWTH FACTOR; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR; STROMAL CELL DERIVED FACTOR 1; SURVIVIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

APOPTOSIS; CARCINOGENICITY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; FIBROGENESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOGENICITY; IMMUNOMODULATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER FUNCTION; LIVER REGENERATION; LIVER RESECTION; LIVER TRANSPLANTATION; METASTASIS; NONHUMAN; REVIEW; TUMOR GROWTH;

BONE MARROW STROMAL CELLS; LIVER CANCER; LIVER METASTASIS; LIVER REGENERATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER REGENERATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; TREATMENT OUTCOME;

EID: 84891815031     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i1.126     Document Type: Review

References (69)

1. Michalopoulos GK, DeFrances M. Liver regeneration. Adv Biochem Eng Biotechnol 2005; 93: 101-134 [PMID: 15791946 DOI: 10.1007/b99968]
2. Duncan AW, Dorrell C, Grompe M. Stem cells and liver regeneration. Gastroenterology 2009; 137: 466-481 [PMID: 19470389 DOI: 10.1053/j.gastro.2009.05.044]
3. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, Taub R. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379-1383 [PMID: 8910279 DOI: 10.1126/science.274.5291.1379]
4. Baba HA, Wohlschlaeger J, Schmitz KJ, Nadalin S, Lang H, Benesch A, Gu Y, Biglarnia AR, Sotiropoulos GC, Takeda A, Takeda N, von Wnuck Lipinski K, Levkau B. Survivin is upregulated during liver regeneration in rats and humans and is associated with hepatocyte proliferation. Liver Int 2009; 29: 585-592 [PMID: 19018973 DOI: 10.1111/ j.1478-3231.2008.01911.x]
5. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147 [PMID: 10102814 DOI: 10.1126/science.284.5411.143]
6. Xu S, Xu Y. Recent progress of BMSCs acting as seeding cell for tissue engineered cartilage. Zhongguo Xiufu Chongjian Waike Zazhi 2008; 22: 163-166 [PMID: 18365611]
7. Mohammadi R, Azizi S, Delirezh N, Hobbenaghi R, Amini K, Malekkhetabi P. The use of undifferentiated bone marrow stromal cells for sciatic nerve regeneration in rats. Int J Oral Maxillofac Surg 2012; 41: 650-656 [PMID: 22154576 DOI: 10.1016/j.ijom.2011.10.028]
8. Zhao C, Chieh HF, Bakri K, Ikeda J, Sun YL, Moran SL, An KN, Amadio PC. The effects of bone marrow stromal cell transplants on tendon healing in vitro. Med Eng Phys 2009; 31: 1271-1275 [PMID: 19736035 DOI: 10.1016/ j.medengphy.2009.08.004]
9. Pang CJ, Tong L, Ji LL, Wang ZY, Zhang X, Gao H, Jia H, Zhang LX, Tong XJ. Synergistic effects of ultrashort wave and bone marrow stromal cells on nerve regeneration with acellular nerve allografts. Synapse 2013; 67: 637-647 [PMID: 23554017 DOI: 10.1002/syn.21669]
10. Li XH, Fu YH, Lin QX, Liu ZY, Shan ZX, Deng CY, Zhu JN, Yang M, Lin SG, Li Y, Yu XY. Induced bone marrow mesenchymal stem cells improve cardiac performance of infarcted rat hearts. Mol Biol Rep 2012; 39: 1333-1342 [PMID: 21667244 DOI: 10.1007/s11033-011-0867-2]
11. Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Watt S, Martin-Rendon E. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2012; 2: CD006536 [PMID: 22336818 DOI: 10.1002/14651858. CD006536.pub3]
12. Eleuterio E, Trubiani O, Sulpizio M, Di Giuseppe F, Pierdomenico L, Marchisio M, Giancola R, Giammaria G, Miscia S, Caputi S, Di Ilio C, Angelucci S. Proteome of human stem cells from periodontal ligament and dental pulp. PLoS One 2013; 8: e71101 [PMID: 23940696 DOI: 10.1371/journal. pone.0071101]
13. Nussler A, Konig S, Ott M, Sokal E, Christ B, Thasler W, Brulport M, Gabelein G, Schormann W, Schulze M, Ellis E, Kraemer M, Nocken F, Fleig W, Manns M, Strom SC, Hengstler JG. Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 2006; 45: 144-159 [PMID: 16730092 DOI: 10.1016/j.jhep.2006.04.002]
14. Jeong JA, Ko KM, Bae S, Jeon CJ, Koh GY, Kim H. Genomewide differential gene expression profiling of human bone marrow stromal cells. Stem Cells 2007; 25: 994-1002 [PMID: 17420227 DOI: 10.1634/stemcells.2006-0604]
15. Yamaguchi S, Kuroda S, Kobayashi H, Shichinohe H, Yano S, Hida K, Shinpo K, Kikuchi S, Iwasaki Y. The effects of neuronal induction on gene expression profile in bone marrow stromal cells (BMSC)--a preliminary study using microarray analysis. Brain Res 2006; 1087: 15-27 [PMID: 16626644 DOI: 10.1016/j.brainres.2006.02.127]
16. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 2007; 25: 2739-2749 [PMID: 17656645]
17. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, Yang VW, Lee OK. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008; 134: 2111-221+2111-221 [PMID: 18455168 DOI: 10.1053/ j.gastro.2008.03.015]
18. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kawamata M, Kato T, Okochi H, Ochiya T. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury. Stem Cells 2008; 26: 2705-2712 [PMID: 18535155 DOI: 10.1634/stemcells.2008-0034]
19. Qihao Z, Xigu C, Guanghui C, Weiwei Z. Spheroid formation and differentiation into hepatocyte-like cells of rat mesenchymal stem cell induced by co-culture with liver cells. DNA Cell Biol 2007; 26: 497-503 [PMID: 17630854 DOI: 10.1089/dna.2006.0562]
20. Arikura J, Inagaki M, Huiling X, Ozaki A, Onodera K, Ogawa K, Kasai S. Colonization of albumin-producing hepatocytes derived from transplanted F344 rat bone marrow cells in the liver of congenic Nagase's analbuminemic rats. J Hepatol 2004; 41: 215-221 [PMID: 15288469 DOI: 10.1016/ j.jhep.2004.04.020]
21. Mavros MN, Mayo SC, Hyder O, Pawlik TM. A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma. J Am Coll Surg 2012; 215: 820-830 [PMID: 22981432 DOI: 10.1016/j.jamcollsurg.2012.0 8.001]
22. Göbel T, Blondin D, Kolligs F, Bölke E, Erhardt A. Current therapy of hepatocellular carcinoma with special consideration of new and multimodal treatment concepts. Dtsch Med Wochenschr 2013; 138: 1425-1430 [PMID: 23801265 DOI: 10.1055/s-0033-1343232]
23. Grant RC, Sandhu L, Dixon PR, Greig PD, Grant DR, McGilvray ID. Living vs. deceased donor liver transplantation for hepatocellular carcinoma: a systematic review and metaanalysis. Clin Transplant 2013; 27: 140-147 [PMID: 23157398 DOI: 10.1111/ctr.12031]
24. Villanueva A, Llovet JM. Targeted therapies for hepatocellular carcinoma. Gastroenterology 2011; 140: 1410-1426 [PMID: 21406195 DOI: 10.1053/j.gastro.2011.03.006]
25. Yu L, Dai Z, Wang Z, Fan J, Zhou J. Prognostic indicators for tumor recurrence after liver transplantation in hepatocellular carcinoma and related molecular targeted therapy. Oncology 2011; 81(Suppl 1): 116-122 [PMID: 22212945 DOI: 10.1159/000333273]
26. Qiao L, Xu Z, Zhao T, Zhao Z, Shi M, Zhao RC, Ye L, Zhang X. Suppression of tumorigenesis by human mesenchymal stem cells in a hepatoma model. Cell Res 2008; 18: 500-507 [PMID: 18364678 DOI: 10.1038/cr.2008.40]
27. Abdel aziz MT, El Asmar MF, Atta HM, Mahfouz S, Fouad HH, Roshdy NK, Rashed LA, Sabry D, Hassouna AA, Taha FM. Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling. J Exp Clin Cancer Res 2011; 30: 49 [PMID: 21545718 DOI: 10.1186/1756-9966-30-49]
28. Friedman SL. Liver fibrosis - from bench to bedside. J Hepatol 2003; 38(Suppl 1): S38-S53 [PMID: 12591185 DOI: 10.1016/S0168-8278(02)00429-4]
29. Shek FW, Benyon RC. How can transforming growth factor beta be targeted usefully to combat liver fibrosis? Eur J Gastroenterol Hepatol 2004; 16: 123-126 [PMID: 15075983 DOI: 10.1097/00042737-200402000-00001]
30. Nitta T, Kim JS, Mohuczy D, Behrns KE. Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways. Hepatology 2008; 48: 909-919 [PMID: 18712785 DOI: 10.1002/hep.22397]
31. van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, Huber H, Eferl R, Beug H, Dolznig H, Mikulits W. Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene 2009; 28: 4022-4033 [PMID: 19718050 DOI: 10.1038/onc.2009.253]
32. Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O, Charbord P, Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007; 25: 1737-1745 [PMID: 17395768 DOI: 10.1634/stemcells.2007-0054]
33. Abdel Aziz MT, Atta HM, Mahfouz S, Fouad HH, Roshdy NK, Ahmed HH, Rashed LA, Sabry D, Hassouna AA, Hasan NM. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 2007; 40: 893-899 [PMID: 17543295 DOI: 10.1016/ j.clinbiochem.2007.04.017]
34. Zhao DC, Lei JX, Chen R, Yu WH, Zhang XM, Li SN, Xiang P. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 2005; 11: 3431-3440 [PMID: 15948250]
35. Oyagi S, Hirose M, Kojima M, Okuyama M, Kawase M, Nakamura T, Ohgushi H, Yagi K. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. J Hepatol 2006; 44: 742-748 [PMID: 16469408 DOI: 10.1016/j.jhep.2005.10.026]
36. Ishikawa H, Jo JI, Tabata Y. Liver Anti-Fibrosis Therapy with Mesenchymal Stem Cells Secreting Hepatocyte Growth Factor. J Biomater Sci Polym Ed 2011 Dec 14; Epub ahead of print [PMID: 22182291]
37. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74 [PMID: 9082988 DOI: 10.1126/science.276.5309.71]
38. Bergfeld SA, DeClerck YA. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev 2010; 29: 249-261 [PMID: 20411303 DOI: 10.1007/s10555-010-9222-7]
39. Ma M, Ye JY, Deng R, Dee CM, Chan GC. Mesenchymal stromal cells may enhance metastasis of neuroblastoma via SDF-1/CXCR4 and SDF-1/CXCR7 signaling. Cancer Lett 2011; 312: 1-10 [PMID: 21906874 DOI: 10.1016/ j.canlet.2011.06.028]
40. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557-563 [PMID: 17914389 DOI: 10.1038/nature06188]
41. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D. Carcinomaassociated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 2008; 68: 4331-4339 [PMID: 18519693 DOI: 10.1158/0008-5472]
42. Molloy AP, Martin FT, Dwyer RM, Griffin TP, Murphy M, Barry FP, O'Brien T, Kerin MJ. Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int J Cancer 2009; 124: 326-332 [PMID: 19003962 DOI: 10.1002/ijc.23939]
43. Gao H, Priebe W, Glod J, Banerjee D. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium. Stem Cells 2009; 27: 857-865 [PMID: 19350687]
44. Li GC, Ye QH, Xue YH, Sun HJ, Zhou HJ, Ren N, Jia HL, Shi J, Wu JC, Dai C, Dong QZ, Qin LX. Human mesenchymal stem cells inhibit metastasis of a hepatocellular carcinoma model using the MHCC97-H cell line. Cancer Sci 2010; 101: 2546-2553 [PMID: 20942864 DOI: 10.1111/ j.1349-7006.2010.01738.x]
45. Yang L, Inokuchi S, Roh YS, Song J, Loomba R, Park EJ, Seki E. Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1. Gastroenterology 2013; 144: 1042-1054.e4 [PMID: 23391818 DOI: 10.1053/ j.gastro.2013.01.056]
46. Bertran E, Crosas-Molist E, Sancho P, Caja L, Lopez-Luque J, Navarro E, Egea G, Lastra R, Serrano T, Ramos E, Fabregat I. Overactivation of the TGF-β pathway confers a mesenchymal-like phenotype and CXCR4-dependent migratory properties to liver tumor cells. Hepatology 2013; 58: 2032-2044 [PMID: 23813475 DOI: 10.1002/hep.26597]
47. Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Watt S, Martin-Rendon E. Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev 2012; 2: CD006536 [PMID: 22336818 DOI: 10.1002/14651858.CD006536.pub3]
48. Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 2010; 29: 1787-1797 [PMID: 20023698 DOI: 10.1038/onc.2009.468]
49. Benetti A, Berenzi A, Gambarotti M, Garrafa E, Gelati M, Dessy E, Portolani N, Piardi T, Giulini SM, Caruso A, Invernici G, Parati EA, Nicosia R, Alessandri G. Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium. Cancer Res 2008; 68: 8626-8634 [PMID: 18922939 DOI: 10.1158/0008-5472.CAN-08-1218]
50. Padua D, Massagué J. Roles of TGFbeta in metastasis. Cell Res 2009; 19: 89-102 [PMID: 19050696]
51. Matsuzaki K, Murata M, Yoshida K, Sekimoto G, Uemura Y, Sakaida N, Kaibori M, Kamiyama Y, Nishizawa M, Fujisawa J, Okazaki K, Seki T. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology 2007; 46: 48-57 [PMID: 17596875 DOI: 10.1002/hep.21672]
52. Murata M, Matsuzaki K, Yoshida K, Sekimoto G, Tahashi Y, Mori S, Uemura Y, Sakaida N, Fujisawa J, Seki T, Kobayashi K, Yokote K, Koike K, Okazaki K. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B. Hepatology 2009; 49: 1203-1217 [PMID: 19263472 DOI: 10.1002/hep.22765]
53. Massagué J. TGFbeta in Cancer. Cell 2008; 134: 215-230 [PMID: 18662538 DOI: 10.1016/j.cell.2008.07.001]
54. Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, Delattre O. Mesenchymal stem cell features of Ewing tumors. Cancer Cell 2007; 11: 421-429 [PMID: 17482132 DOI: 10.1016/j.ccr.2007.02.027]
55. Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR, Wang TC. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306: 1568-1571 [PMID: 15567866 DOI: 10.1126/science.1099513]
56. Dawson MR, Chae SS, Jain RK, Duda DG. Direct evidence for lineage-dependent effects of bone marrow stromal cells on tumor progression. Am J Cancer Res 2011; 1: 144-154 [PMID: 21822499]
57. Coulouarn C, Factor VM, Thorgeirsson SS. Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer. Hepatology 2008; 47: 2059-2067 [PMID: 18506891 DOI: 10.1002/ hep.22283]
58. Prigione I, Benvenuto F, Bocca P, Battistini L, Uccelli A, Pistoia V. Reciprocal interactions between human mesenchymal stem cells and gammadelta T cells or invariant natural killer T cells. Stem Cells 2009; 27: 693-702 [PMID: 19096038 DOI: 10.1634/stemcells.2008-0687]
59. Galiè M, Konstantinidou G, Peroni D, Scambi I, Marchini C, Lisi V, Krampera M, Magnani P, Merigo F, Montani M, Boschi F, Marzola P, Orrù R, Farace P, Sbarbati A, Amici A. Mesenchymal stem cells share molecular signature with mesenchymal tumor cells and favor early tumor growth in syngeneic mice. Oncogene 2008; 27: 2542-2551 [PMID: 17998939]
60. Shi LJ, Li SX, Sun B, Wang JH, Li HL, Jin LH. Effects of bone marrow mesenchymal stem cells on the proliferation of hepatocytes and cirrhotic fat-storing cells in vitro. Zhonghua Ganzangbing Zazhi 2007; 15: 681-684 [PMID: 17903371]
61. Ke Z, Zhou F, Wang L, Chen S, Liu F, Fan X, Tang F, Liu D, Zhao G. Down-regulation of Wnt signaling could promote bone marrow-derived mesenchymal stem cells to differentiate into hepatocytes. Biochem Biophys Res Commun 2008; 367: 342-348 [PMID: 18174024 DOI: 10.1016/j.bbrc.2007.12.134]
62. Lin N, Lin J, Bo L, Weidong P, Chen S, Xu R. Differentiation of bone marrow-derived mesenchymal stem cells into hepatocytelike cells in an alginate scaffold. Cell Prolif 2010; 43: 427-434 [PMID: 20887549 DOI: 10.1111/j.1365-2184.2010.00692.x]
63. Feng Z, Li C, Jiao S, Hu B, Zhao L. In vitro differentiation of rat bone marrow mesenchymal stem cells into hepatocytes. Hepatogastroenterology 2011; 58: 2081-2086 [PMID: 22024079 DOI: 10.5754/hge11220]
64. Zhao L, Feng Z, Hu B, Chi X, Jiao S. Ex vivo-expanded bone marrow mesenchymal stem cells facilitate recovery from chemically induced acute liver damage. Hepatogastroenterology 2012; 59: 2389-2394 [PMID: 22641077]
65. Haraguchi T, Tani K, Takagishi R, Oda Y, Itamoto K, Yamamoto N, Terai S, Sakaida I, Nakazawa H, Taura Y. Therapeutic potential of canine bone marrow stromal cells (BMSCs) in the carbon tetrachloride (CCl4) induced chronic liver dysfunction mouse model. J Vet Med Sci 2012; 74: 607-611 [PMID: 22198059]
66. Dalakas E, Newsome PN, Boyle S, Brown R, Pryde A, McCall S, Hayes PC, Bickmore WA, Harrison DJ, Plevris JN. Bone marrow stem cells contribute to alcohol liver fibrosis in humans. Stem Cells Dev 2010; 19: 1417-1425 [PMID: 20025456 DOI: 10.1089/scd.2009.0387]
67. Li J, Wu W, Xin J, Guo J, Jiang L, Tao R, Cao H, Hong X, Li L. Acute hepatic failure-derived bone marrow mesenchymal stem cells express hepatic progenitor cell genes. Cells Tissues Organs 2011; 194: 371-381 [PMID: 21293100 DOI: 10.1159/000322604]
68. Li C, Kong Y, Wang H, Wang S, Yu H, Liu X, Yang L, Jiang X, Li L, Li L. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 2009; 50: 1174-1183 [PMID: 19398237 DOI: 10.1016/j.jhep.2009.01.028]
69. Luetzkendorf J, Mueller LP, Mueller T, Caysa H, Nerger K, Schmoll HJ. Growth inhibition of colorectal carcinoma by lentiviral TRAIL-transgenic human mesenchymal stem cells requires their substantial intratumoral presence. J Cell Mol Med 2010; 14: 2292-2304 [PMID: 19508388 DOI: 10.1111/ j.1582-4934.2009.00794.x]